Guj. Themis Bio.

34
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
363.35
-4.45 (-1.21%)
BSENSE

Oct 09

BSE+NSE Vol: 4.19 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 9.96% vs -11.20% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 9.71% vs -12.56% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 710.14% vs 58.81% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -4.29% vs -17.56% in Mar 2025

Compare Profit and Loss Results of Guj. Themis Bio.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
165.00
354.00
-189.00
-53.39%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
165.00
354.00
-189.00
-53.39%
Expenditure (Ex Depriciation)
Stock Adjustments
-9.00
-12.00
3.00
25.00%
Raw Materials Consumed
30.00
210.00
-180.00
-85.71%
Power & Fuel Cost
31.00
0.00
31.00
0%
Employee Cost
14.00
21.00
-7.00
-33.33%
Operating Expenses
7.00
9.00
-2.00
-22.22%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
11.00
-11.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
6.00
-1.00
-16.67%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
90.00
260.00
-170.00
-65.38%
Operating Profit (PBDIT) excl Other Income
75.00
94.00
-19.00
-20.21%
Other Income
2.00
38.00
-36.00
-94.74%
Operating Profit (PBDIT)
77.00
132.00
-55.00
-41.67%
Interest
2.00
1.00
1.00
100.00%
Profit before Depriciation and Tax
75.00
131.00
-56.00
-42.75%
Depreciation
12.00
1.00
11.00
1,100.00%
Profit Before Taxation & Exceptional Items
62.00
129.00
-67.00
-51.94%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
62.00
129.00
-67.00
-51.94%
Provision for Tax
15.00
36.00
-21.00
-58.33%
Profit After Tax
46.00
93.00
-47.00
-50.54%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
237.00
768.00
-531.00
-69.14%
Profit Available for appropriations
284.00
862.00
-578.00
-67.05%
Appropriations
284.00
862.00
-578.00
-67.05%
Equity Dividend (%)
67%
500%
-433.00
Earnings Per Share
4.28
37.74
-33.46
-88.66%
Profit And Loss - Net Sales
Net Sales 165.82 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 9.96% vs -11.20% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 75.53 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 9.71% vs -12.56% in Mar 2025

Profit And Loss - Interest
Interest 2.95 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 710.14% vs 58.81% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 46.68 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -4.29% vs -17.56% in Mar 2025